| Dr Michael R Laffer, DO | |
|
27483 Dequindre Rd, Suite 210, Madison Heights, MI 48071-3491 | |
| (248) 398-4081 | |
| (248) 398-4527 |
| Full Name | Dr Michael R Laffer |
|---|---|
| Gender | Male |
| Speciality | Pulmonary Disease |
| Experience | 49 Years |
| Location | 27483 Dequindre Rd, Madison Heights, Michigan |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1639153497 | NPI | - | NPPES |
| 700H217350 | Other | MI | BLUE SHIELD |
| E26387 | Other | MI | HAP |
| 290008653 | Other | MI | RR MEDICARE |
| 120786 | Other | MI | CARE-PREFERRED CHOICES |
| 1639153497 | Medicaid | MI |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RP1001X | Internal Medicine - Pulmonary Disease | 5101006980 (Michigan) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Ascension Macomb Oakland Hosp-warren Campus | Warren, MI | Hospital |
| Ascension Providence Hospital, Southfield And Novi | Southfield, MI | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Michigan Healthcare Professionals Pc | 0345413258 | 448 |
| Doctors Diagnostic Center, Pc | 2769463272 | 4 |
| Omg 1pc | 4183536238 | 17 |
| Mmg 1 Pc | 6103738638 | 7 |
News Archive
ImmunoGen, Inc., a biopharmaceutical company that develops targeted anticancer therapeutics, announced today that it has priced a public offering of 9,000,000 shares of its common stock at a price of $8.00 per share.
In a clinical phase-3-study, an international research cooperation of MedUni Vienna and Stanford University has achieved significant success with the drug Baricitinib for the treatment of rheumatoid arthritis. The test persons exhibited significantly less symptoms of the disorder. The results are now published in the top scientific journal "New England Journal of Medicine".
Beauty therapist, Jo Anastasio, who suffers from an extremely rare blood vessel abnormality, was told that she couldn't have children and that her only option was a hysterectomy.
Coronavirus could pose a significant risk for people living with dementia in the UK – the Government must prioritise their welfare in the coming weeks.
Two leading neurology researchers have proposed a theory that could unify scientists' thinking about several neurodegenerative diseases and suggest therapeutic strategies to combat them.
› Verified 4 days ago
| Entity Name | Mmg 1 Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1912933540 PECOS PAC ID: 6103738638 Enrollment ID: O20031104000106 |
News Archive
ImmunoGen, Inc., a biopharmaceutical company that develops targeted anticancer therapeutics, announced today that it has priced a public offering of 9,000,000 shares of its common stock at a price of $8.00 per share.
In a clinical phase-3-study, an international research cooperation of MedUni Vienna and Stanford University has achieved significant success with the drug Baricitinib for the treatment of rheumatoid arthritis. The test persons exhibited significantly less symptoms of the disorder. The results are now published in the top scientific journal "New England Journal of Medicine".
Beauty therapist, Jo Anastasio, who suffers from an extremely rare blood vessel abnormality, was told that she couldn't have children and that her only option was a hysterectomy.
Coronavirus could pose a significant risk for people living with dementia in the UK – the Government must prioritise their welfare in the coming weeks.
Two leading neurology researchers have proposed a theory that could unify scientists' thinking about several neurodegenerative diseases and suggest therapeutic strategies to combat them.
› Verified 4 days ago
| Entity Name | Omg 1pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1891737466 PECOS PAC ID: 4183536238 Enrollment ID: O20031105000645 |
News Archive
ImmunoGen, Inc., a biopharmaceutical company that develops targeted anticancer therapeutics, announced today that it has priced a public offering of 9,000,000 shares of its common stock at a price of $8.00 per share.
In a clinical phase-3-study, an international research cooperation of MedUni Vienna and Stanford University has achieved significant success with the drug Baricitinib for the treatment of rheumatoid arthritis. The test persons exhibited significantly less symptoms of the disorder. The results are now published in the top scientific journal "New England Journal of Medicine".
Beauty therapist, Jo Anastasio, who suffers from an extremely rare blood vessel abnormality, was told that she couldn't have children and that her only option was a hysterectomy.
Coronavirus could pose a significant risk for people living with dementia in the UK – the Government must prioritise their welfare in the coming weeks.
Two leading neurology researchers have proposed a theory that could unify scientists' thinking about several neurodegenerative diseases and suggest therapeutic strategies to combat them.
› Verified 4 days ago
| Entity Name | Doctors Diagnostic Center, Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1942392196 PECOS PAC ID: 2769463272 Enrollment ID: O20040528000818 |
News Archive
ImmunoGen, Inc., a biopharmaceutical company that develops targeted anticancer therapeutics, announced today that it has priced a public offering of 9,000,000 shares of its common stock at a price of $8.00 per share.
In a clinical phase-3-study, an international research cooperation of MedUni Vienna and Stanford University has achieved significant success with the drug Baricitinib for the treatment of rheumatoid arthritis. The test persons exhibited significantly less symptoms of the disorder. The results are now published in the top scientific journal "New England Journal of Medicine".
Beauty therapist, Jo Anastasio, who suffers from an extremely rare blood vessel abnormality, was told that she couldn't have children and that her only option was a hysterectomy.
Coronavirus could pose a significant risk for people living with dementia in the UK – the Government must prioritise their welfare in the coming weeks.
Two leading neurology researchers have proposed a theory that could unify scientists' thinking about several neurodegenerative diseases and suggest therapeutic strategies to combat them.
› Verified 4 days ago
| Entity Name | Michigan Healthcare Professionals Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1295023547 PECOS PAC ID: 0345413258 Enrollment ID: O20111109000027 |
News Archive
ImmunoGen, Inc., a biopharmaceutical company that develops targeted anticancer therapeutics, announced today that it has priced a public offering of 9,000,000 shares of its common stock at a price of $8.00 per share.
In a clinical phase-3-study, an international research cooperation of MedUni Vienna and Stanford University has achieved significant success with the drug Baricitinib for the treatment of rheumatoid arthritis. The test persons exhibited significantly less symptoms of the disorder. The results are now published in the top scientific journal "New England Journal of Medicine".
Beauty therapist, Jo Anastasio, who suffers from an extremely rare blood vessel abnormality, was told that she couldn't have children and that her only option was a hysterectomy.
Coronavirus could pose a significant risk for people living with dementia in the UK – the Government must prioritise their welfare in the coming weeks.
Two leading neurology researchers have proposed a theory that could unify scientists' thinking about several neurodegenerative diseases and suggest therapeutic strategies to combat them.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Michael R Laffer, DO 27483 Dequindre Rd, Suite 210, Madison Heights, MI 48071-3491 Ph: (248) 398-4081 | Dr Michael R Laffer, DO 27483 Dequindre Rd, Suite 210, Madison Heights, MI 48071-3491 Ph: (248) 398-4081 |
News Archive
ImmunoGen, Inc., a biopharmaceutical company that develops targeted anticancer therapeutics, announced today that it has priced a public offering of 9,000,000 shares of its common stock at a price of $8.00 per share.
In a clinical phase-3-study, an international research cooperation of MedUni Vienna and Stanford University has achieved significant success with the drug Baricitinib for the treatment of rheumatoid arthritis. The test persons exhibited significantly less symptoms of the disorder. The results are now published in the top scientific journal "New England Journal of Medicine".
Beauty therapist, Jo Anastasio, who suffers from an extremely rare blood vessel abnormality, was told that she couldn't have children and that her only option was a hysterectomy.
Coronavirus could pose a significant risk for people living with dementia in the UK – the Government must prioritise their welfare in the coming weeks.
Two leading neurology researchers have proposed a theory that could unify scientists' thinking about several neurodegenerative diseases and suggest therapeutic strategies to combat them.
› Verified 4 days ago
Dr. Gary Langnas, D.O. Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 27483 Dequindre Rd, Suite 302, Madison Heights, MI 48071 Phone: 248-547-6603 Fax: 248-547-5696 | |
Dr. Savitha Balaraman, MD Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 27301 Dequindre Rd, Ste 314, Madison Heights, MI 48071 Phone: 248-399-4400 Fax: 248-399-4840 | |
Dr. Gary L Berg, D.O. Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 27483 Dequindre Rd, Suite 210, Madison Heights, MI 48071 Phone: 248-398-4081 Fax: 248-398-4527 | |
Dr. Harold Margolis, DO Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 27301 Dequindre Rd, Ste 314, Madison Heights, MI 48071 Phone: 248-399-4400 Fax: 248-399-4840 | |
Dr. Robert E Reid Ii, M.D. Pulmonary Disease Medicare: Not Enrolled in Medicare Practice Location: 27301 Dequindre Rd, Suite 314, Madison Heights, MI 48071 Phone: 248-399-4400 Fax: 248-399-4840 | |
Dr. Michael Berkovic, DO Pulmonary Disease Medicare: Not Enrolled in Medicare Practice Location: 27301 Dequindre Rd, Ste 314, Madison Heights, MI 48071 Phone: 248-399-4400 Fax: 248-399-4840 | |
Dr. Stephen M Hoffman, D.O. Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 27301 Dequindre Rd, Suite 314, Madison Heights, MI 48071 Phone: 248-399-4400 Fax: 248-399-4840 |